One in five adults said they experienced any symptoms of anxiety or depression in a 2-week period, according to a 2022 CDC ...

"This data gives patients the option to benefit from esketamine treatment either with or without an antidepressant," said ...

The US drugs regulator has approved the sale of a new nasal spray to treat depression. Manufacturer Janssen says Esketamine can lift a patient's mood within 24 hours of use. The drug is intended ...

The nasal spray version, esketamine, has also been found to ease ... was reportedly “receiving ketamine infusion therapy for ...

It's helped them immensely." Veterans use the nasal spray esketamine to treat mental health conditions such as PTSD, chronic depression, and anxiety. Although Chris doesn’t use esketamine himself, he ...

An esketamine-based nasal spray antidepressant for adults is under review in the US following a filing from Johnson & Johnson's pharma unit. Janssen has submitted a filing for esketamine to the US ...

Janssen, which is Johnson & Johnson’s pharma unit, submitted a filing to the European Medicines Agency for esketamine nasal spray, which is designed to help people with treatment-resistant ...

(TMS). We are now providing one of the most advanced FDA cleared treatments for depression including NeuroStar TMS Therapy and Spravato (Esketamine) Nasal Spray. A board-certified Psychiatrist (MD ...

Presentations include new data supporting the safety and efficacy of SPRAVATO® (esketamine) CIII nasal spray and the Company's innovative portfolio of long-acting injectables (LAIs) for ...

Mental health is a vital aspect of overall well-being, especially for students who face unique pressures and challenges. From ...

The FDA updated a warning on the label of esketamine nasal spray (Spravato ... A psychiatrist explains the difference between "normal" anxiety and an anxiety disorder. (Washington Post) Brief ...